AstraZeneca's Imfinzi shows promise in treating aggressive lung cancer

The drug demonstrated "statistically significant and clinically meaningful improvement" in the dual primary goals of overall survival and progression-free survival in patients for whom the disease had not worsened following concurrent chemoradiotherapy in a late-stage trial, according to AstraZeneca.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Kl9yWGm
via